Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab

ABP 215 is a biosimilar product to bevacizumab. Bevacizumab acts by binding to vascular endothelial growth factor A, inhibiting endothelial cell proliferation and new blood vessel formation, thereby leading to tumor vasculature normalization. The ABP 215 analytical similarity assessment was designed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Seo, Neungseon, Polozova, Alla, Zhang, Mingxuan, Yates, Zachary, Cao, Shawn, Li, Huimin, Kuhns, Scott, Maher, Gwendolyn, McBride, Helen J., Liu, Jennifer
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5973752/
https://ncbi.nlm.nih.gov/pubmed/29553864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1452580
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados